Aravive, Inc. Contracts & Agreements

118 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
General Assignment for the Benefit of Creditors, dated January 17, 2024, by and between Aravive, Inc. and Aravive (assignment for the benefit of creditors), LLC
Assignment Agreements
Aravive, Inc.
2024
Separation Agreement and Release by and between Gail McIntyre, Ph.D. and Aravive, Inc., dated January 17, 2024
Separation Agreements
Aravive, Inc.
2024
Separation Agreement and Release by and between Rudy C. Howard and Aravive, Inc., dated January 17, 2024
Separation Agreements
Aravive, Inc.
2024
Offer Letter, dated April 10, 2023, by and between Aravive, Inc. and Maria Carolina Petrini
Aravive, Inc.
2023
Inducement Stock Option Grant Notice and Aravive, Inc. Inducement Stock Option Agreement, dated April 10, 2023, by and between Aravive, Inc. and Maria Carolina Petrini
Stock Agreements
Aravive, Inc.
2023
Description of Capital Securities
Aravive, Inc.
Biotechnology
2023
Amendment No. 3 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Gail McIntyre, Ph.D
Aravive, Inc.
Biotechnology
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and RudyHoward
Aravive, Inc.
Biotechnology
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Robert Geller, M.D
Aravive, Inc.
2023
Amendment No. 1 to Offer Letter dated as of February 1, 2023 by and between Aravive, Inc. and Leonard Scott Dove, Ph.D
Aravive, Inc.
Biotechnology
2023
Form of Securities Purchase Agreement, dated October 24, 2022, by and among Aravive, Inc. and the purchasers party thereto
Purchase Agreements
Aravive, Inc.
Biotechnology
NY
2022
Form of Pre-Funded Warrant
Warrant Agreements
Aravive, Inc.
Biotechnology
NY
2022
Form of Series A Warrant
Warrant Agreements
Aravive, Inc.
2022
Form of Series B Warrant
Warrant Agreements
Aravive, Inc.
2022
Form of Securities Purchase Agreement, dated October 24, 2022, by and among Aravive, Inc. and the purchasers party thereto
Purchase Agreements
Aravive, Inc.
2022
Form of Side Letter Agreement by and among Aravive, Inc. and the persons party thereto
Aravive, Inc.
2022
Form of Side Letter Agreement by and among Aravive, Inc. and the BVF Investor party thereto
Aravive, Inc.
Biotechnology
NY
2022
Form of Registration Rights Agreement by and among Aravive, Inc. and the persons party thereto
Registration Rights Agreements
Aravive, Inc.
2022
Form of Affiliate Registration Rights Agreement, by and among Aravive, Inc. and the persons party thereto
Registration Rights Agreements
Aravive, Inc.
2022
Offer Letter, dated June 13, 2022, by and between Aravive, Inc. and Dr. Robert B. Geller
Aravive, Inc.
2022
Offer Letter, dated June 2, 2022, by and between Aravive, Inc. and Rudy C. Howard
Aravive, Inc.
2022
Consulting Agreement, dated June 2, 2022, by and between Aravive, Inc. and Vinay Shah
Consulting Agreements
Aravive, Inc.
2022
Separation Agreement and Release, dated June 2, 2022, by and between Aravive, Inc. and Vinay Shah
Separation Agreements
Aravive, Inc.
2022
Form of Investor Warrant
Warrant Agreements
Aravive, Inc.
2022
Form of Eshelman Warrant
Warrant Agreements
Aravive, Inc.
2022
Form of Pre-Funded Warrant
Warrant Agreements
Aravive, Inc.
Biotechnology
2022
Form of Securities Purchase Agreement, dated March 29, 2022 by and between Aravive, Inc. and the purchaser party thereto
Purchase Agreements
Aravive, Inc.
2022
Form of Securities Purchase Agreement, dated March 29, 2022 by and between Aravive, Inc. and Eshelman Ventures, LLC
Purchase Agreements
Aravive, Inc.
Biotechnology
NY
2022
Offer Letter between Leonard Scott Dove, Ph.D. and Aravive, Inc
Aravive, Inc.
2022
Form of Pre-Funded Common Stock Purchase Warrant of Aravive, Inc
Warrant Agreements
Aravive, Inc.
Biotechnology
DE
2022
Investment Agreement, dated as of January 3, 2022, by and among Aravive, Inc., Eshelman Ventures, LLC, and solely for purposes of Article IV and V of the Investment Agreement,...
Investment Agreements
Aravive, Inc.
Biotechnology
DE
2022
Sublease Agreement by and between Aravive, Inc. and Grail, Inc
Lease Agreements
Aravive, Inc.
2021
Description of Capital Securities
Aravive, Inc.
Biotechnology
2021
Offer Letter, dated September 8, 2020 between Reshma Rangwala and the Company
Aravive, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement, dated February 12, 2021, by and between Aravive, Inc. and Eshelman Ventures, LLC
Purchase Agreements
Aravive, Inc.
Biotechnology
NY
2021
Amendment to Offer Letter dated as of January 25, 2021 by and between Aravive, Inc. and Gail McIntyre, Ph.D
Aravive, Inc.
Biotechnology
2021
Consulting Agreement, dated December 31, 2020, between the Company and Ray Tabibiazar
Consulting Agreements
Aravive, Inc.
2021
Collaboration and License Agreement between Aravive, Inc. and 3D Medicines Inc. dated November 6, 2020
Collaboration Agreements
Aravive, Inc.
Biotechnology
NY
2020
Investment Agreement, dated as of April 6, 2020, by and among the Company, Eshelman Ventures, LLC, and, solely for purposes of Article IV and Article V of the Investment...
Investment Agreements
Aravive, Inc.
Biotechnology
NY
2020
Separation Agreement dated April 8, 2020 between the Company and Rekha Hemrajani
Separation Agreements
Aravive, Inc.
2020
Option Agreement dated April 8, 2020 by and between the Company and Srini Akkaraju
Aravive, Inc.
2020
Option Agreement dated April 8, 2020 by and between the Company and Jay Shepard
Aravive, Inc.
2020
Option Agreement dated April 8, 2020 by and between the Company and Robert Hoffman
Aravive, Inc.
Biotechnology
DE
2020
Amendment to Offer Letter dated as of April 8, 2020 by and between the Company and Gail McIntyre
Aravive, Inc.
Biotechnology
2020
Description of Capital Securities
Aravive, Inc.
Biotechnology
2020
Offer Letter, dated March 26, 2020, between Vinay Shah and Aravive, Inc
Aravive, Inc.
Biotechnology
CA
2020
Offer Letter, dated March 26, 2020 between Gail McIntyre and Aravive, Inc
Aravive, Inc.
2020
Form of 2019 Equity Incentive Plan Restricted Stock Unit Grant Notice and Restricted Stock Unit Award Agreement
Bonus & Incentive Agreements
Aravive, Inc.
Biotechnology
2020
Offer Letter, dated January 8, 2020, between Rekha Hemrajani and Aravive, Inc
Aravive, Inc.
Biotechnology
CA
2020
Separation Agreement, dated January 9, 2020, between Jay Shepard and Aravive, Inc
Separation Agreements
Aravive, Inc.
2020
Consulting Agreement, dated January 9, 2020, between Jay Shepard and Aravive, Inc
Consulting Agreements
Aravive, Inc.
2020
Purchase Agreement, dated November 27, 2019, by and among Aravive, Inc., Piper Jaffray & Co. and Cantor Fitzgerald & Co
Purchase Agreements
Aravive, Inc.
2019
Equity Distribution Agreement, dated as of March 26, 2019, between Aravive, Inc. and Piper Jaffray & Co
Equity Distribution Agreements
Aravive, Inc.
Biotechnology
NY
2019
Non-Employee Director Compensation Policy, as amended January 3, 2019
Compensation Agreements
Aravive, Inc.
2019
Amendment to Jay Shepard Offer Letter dated as of February 28, 2019
Aravive, Inc.
Biotechnology
2019
First Amendment to 2014 Equity Incentive Plan
Bonus & Incentive Agreements
Aravive, Inc.
Biotechnology
2019
Amendment to Jay Shepard Offer Letter dated as of February 6, 2019
Aravive, Inc.
Biotechnology
2019
Offer Letter dated February 1, 2017 and the amendment thereto dated May 30, 2018 by and between Aravive Biologics, Inc. and Vinay Shah
Aravive, Inc.
2019
Severance Agreement dated May 31, 2018 and amendment thereto dated September 24, 2018 between Aravive Biologics, Inc. and Vinay Shah
Severance Agreements
Aravive, Inc.
2019
Offer Letter dated January 1, 2017 by and between Aravive Biologics, Inc. and Gail McIntyre
Aravive, Inc.
Biotechnology
2019
Severance Agreement dated May 31, 2018 and amendment thereto dated September 24, 2018 between Aravive Biologics, Inc. and Gail McIntyre
Severance Agreements
Aravive, Inc.
2019
Separation Agreement with Paul Westberg effective November 15, 2018
Separation Agreements
Aravive, Inc.
2018
Separation Agreement with Tracy Woody effective November 15, 2018
Separation Agreements
Aravive, Inc.
Biotechnology
CA
2018
Sublease dated August 21, 2018, by and among Versartis, Inc. and Eva Automation, Inc
Lease Agreements
Aravive, Inc.
2018
Cancer Research Grant Contract, dated December 1, 2015, by and between the Cancer Prevention and Research Institute of Texas and Ruga Corporation
Aravive, Inc.
2018
Exclusive License Agreement, dated January 25, 2012, by and between The Board of Trustees of the Leland Stanford Junior University and Ruga Corporation
License Agreements
Aravive, Inc.
Biotechnology
CA
2018
Amendment to the Exclusive License Agreement, dated July 26, 2012, by and between the Board of Trustees of Leland Stanford Junior University and Ruga Corporation
License Agreements
Aravive, Inc.
2018
Amendment No. 2 to the Exclusive License Agreement, dated June 29, 2015, by and between The Board of Trustees of the Leland Stanford Junior University and Ruga Corporation
License Agreements
Aravive, Inc.
2018
Amendment No. 3 to the Exclusive License Agreement, dated September 25, 2017, by and between The Board of Trustees of the Leland Stanford Junior University and Ruga Corporation
License Agreements
Aravive, Inc.
2018
Master Manufacturing Services Agreement, dated July 11, 2016, by and between WuXi Biologics (Hong Kong) Limited and Aravive Biologics, Inc
Services Agreements
Aravive, Inc.
Biotechnology
NY
2018
License Agreement, dated December 1, 2017, by and between WuXi Biologics (Hong Kong) Limited and Aravive Biologics, Inc
License Agreements
Aravive, Inc.
Biotechnology
NY
2018
Indemnification Agreement, dated October 17, 2016, by and between Ruga Corporation and Vinay Shah
Indemnification Agreements
Aravive, Inc.
2018
Agreement and Plan of Merger and Reorganization, dated June 3, 2018, by and among Versartis, Inc., Aravive Biologics, Inc. and Velo Merger Sub, Inc
Merger Agreements
Aravive, Inc.
2018
Form of Support Agreement, by and between Versartis, Inc. and Aravive Biologics, Inc.s directors, officers and certain stockholders
Aravive, Inc.
2018
Form of Support Agreement, by and between Aravive Biologics, Inc. and Versartis, Inc.s directors, officers and certain stockholders
Aravive, Inc.
Biotechnology
DE
2018
Offer Letter with Robert Gut, dated August 30, 2017
Aravive, Inc.
2018
Reduction in Force Severance Benefit Plan, dated October 4, 2017
Severance Agreements
Aravive, Inc.
Biotechnology
CA
2018
Separation Agreement with Joshua T. Brumm, dated November 4, 2017
Separation Agreements
Aravive, Inc.
Biotechnology
CA
2018
VERSARTIS, INC. $150,000,000 COMMONSTOCK SALES AGREEMENT
Sales Agreements
Aravive, Inc.
Biotechnology
NY
2017
Amendment No. 2 (hereinafter the "Amendment No. 2") to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the "Agreement")
Supply Agreements
Aravive, Inc.
2017
AMUNIX OPERATING INC. 500 Ellis Street Mountain View, CA 94043
Aravive, Inc.
2017
Operating Lease Agreement by and between Versartis, Inc. and Bohannon Associates dated March 17, 2017
Lease Agreements
Aravive, Inc.
Biotechnology
CA
2017
BI Contract No. 119898 COMMERCIAL SUPPLY AGREEMENT
Supply Agreements
Aravive, Inc.
Biotechnology
CA
2017
EXCLUSIVE LICENSE AND SUPPLY AGREEMENT by and between VERSARTIS GmbH, VERSARTIS, INC. and TEIJIN LIMITED EXCLUSIVE LICENSE AND SUPPLY AGREEMENT
License Agreements
Aravive, Inc.
2016
$60,000,500 VERSARTIS,INC. Common Stock, Par Value $0.0001 Per Share UNDERWRITING AGREEMENT
Underwriting Agreements
Aravive, Inc.
2016
Versartis,Inc. Non-Employee Director Compensation Policy Adopted by the Board: March 3, 2014 Amended by the Compensation Committee: May 21, 2015 Amended by the Compensation...
Compensation Agreements
Aravive, Inc.
Biotechnology
2016
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/27/2015
Aravive, Inc.
Biotechnology
CA
2016
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 02/16/2016
Aravive, Inc.
Biotechnology
CA
2016
Versartis,Inc. Non-Employee Director Compensation Policy Adopted by the Board: March 3, 2014 Amended by the Compensation Committee: May 21, 2015
Compensation Agreements
Aravive, Inc.
2015
4200 Bohannon Drive, Suite 250 | Menlo Park, CA 94025 | 650 ###-###-#### (main)
Aravive, Inc.
2015
Versartis, Inc. 4200 Bohannon Drive, Suite 250 Menlo Park, CA 94025 May 12, 2015
Aravive, Inc.
Biotechnology
CA
2015
[] Shares VERSARTIS, INC. COMMONSTOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Aravive, Inc.
2015
VERSARTIS, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2014 EQUITY INCENTIVE PLAN)
Bonus & Incentive Agreements
Aravive, Inc.
Biotechnology
CA
2014
TECHNOLOGY TRANSFER AND CLINICAL SUPPLYAGREEMENT
Aravive, Inc.
Biotechnology
2014
Amendment No. 1 (hereinafter the Amendment No. 1) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the Agreement)
Supply Agreements
Aravive, Inc.
2014
[] Shares VERSARTIS, INC. COMMONSTOCK, PAR VALUE $0.0001 PER SHARE UNDERWRITING AGREEMENT
Underwriting Agreements
Aravive, Inc.
2014
VERSARTIS, INC. CHANGE IN CONTROL SEVERANCE PLAN
Change of Control Agreements
Aravive, Inc.
2014
VERSARTIS, INC. 2014 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 3, 2014 APPROVED BY THE STOCKHOLDERS:MARCH 5, 2014 IPO DATE/EFFECTIVE DATE:MARCH , 2014
Bonus & Incentive Agreements
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 2014 EMPLOYEE STOCK PURCHASE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 3, 2014 APPROVED BY THE STOCKHOLDERS:MARCH 5, 2014
Stock Agreements
Aravive, Inc.
2014
VERSARTIS, INC. INDEMNIFICATION AGREEMENT
Indemnification Agreements
Aravive, Inc.
2014
AMENDMENT NO. 2 TO SECOND AMENDED AND RESTATED LICENSING AGREEMENT
Aravive, Inc.
Biotechnology
CA
2014
OFFICE LEASE KILROYREALTY MENLO CORPORATE CENTER KILROY REALTY, L.P., a Delaware limited partnership, asLandlord, and VERSARTIS,INC., a Delaware corporation, as Tenant. TABLE OF...
Lease Agreements
Aravive, Inc.
2014
WARRANT TO PURCHASE EQUITY SECURITIES OF VERSARTIS, INC. (Voidafter October , 2017)
Warrant Agreements
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. FOURTHAMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT February 14, 2014 TABLE OF CONTENTS
Investor Rights Agreements
Aravive, Inc.
Biotechnology
DE
2014
Office Lease SHOREBREEZE SHOREBREEZEI REDWOOD CITY, CALIFORNIA Between CA-SHOREBREEZELIMITED PARTNERSHIP, a Delaware limited partnership as Landlord, and VERSARTIS, Inc.,...
Limited Partnership Agreements
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 2009 STOCK PLAN ADOPTED ON FEBRUARY 17, 2009 AS AMENDED ON MAY 13, 2009, SEPTEMBER 10,2010, FEBRUARY 14, 2011, JUNE 16, 2011, JANUARY 18,2012, MAY 1, 2012, OCTOBER...
Stock Agreements
Aravive, Inc.
Biotechnology
2014
VERSARTIS, INC. 2009 STOCK PLAN NOTICE OF STOCK OPTION GRANT (INSTALLMENTVESTING)
Stock Agreements
Aravive, Inc.
2014
VERSARTIS, INC. 2009 STOCK PLAN NOTICE OF STOCK OPTION GRANT (INSTALLMENTVESTING)
Stock Agreements
Aravive, Inc.
2014
TECHNOLOGY TRANSFER AND CLINICAL SUPPLYAGREEMENT
Aravive, Inc.
Biotechnology
2014
Amendment No. 1 (hereinafter the Amendment No. 1) to the Technology Transfer, Clinical Supply Agreement dated October 23, 2012, (hereinafter the Agreement)
Supply Agreements
Aravive, Inc.
Biotechnology
2014
Assignment of Agreement A Technology Transfer and Clinical Supply Agreement dated October 23, 2012 (Contract Number: BI: 63790), including all attachments, amendments and...
Supply Agreements
Aravive, Inc.
2014
SERVICES AGREEMENT
Services Agreements
Aravive, Inc.
2014
SECOND AMENDED AND RESTATED LICENSING AGREEMENT
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 500 Ellis Street Mountain View, CA94043 February 3, 2011
Aravive, Inc.
Biotechnology
2014
AMENDMENT NO. 1 TO SECOND AMENDED AND RESTATED LICENSING AGREEMENT
Aravive, Inc.
2014
VERSARTIS, INC. December 20, 2010
Aravive, Inc.
2014
VERSARTIS, INC. 275 SHORELINE DRIVE, SUITE 450 REDWOOD CITY, CA 94065 November 8, 2013
Aravive, Inc.
Biotechnology
CA
2014
VERSARTIS, INC. 500 ELLIS STREET MOUNTAIN VIEW, CA 94043 February 10, 2011
Aravive, Inc.
2014